Another limitation of our study is that its results cannot be extrapolated to other SLE populations that may differ in their geographical ancestry and risk for G6PD deficiency. Due to the lack of data in our study, sulfasalazine and dapsone and G6PD/anemia were not adequately addressed. Here, G6PD is linked to systemic lupus erythematosus.